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Abstract
Background: Cognitive performance declines with increasing age. Possible cellular mechanisms
underlying this age-related functional decline remain incompletely understood. Early studies
attributed this functional decline to age-related neuronal loss. Subsequent studies using unbiased
stereological techniques found little or no neuronal loss during aging. However, studies using
specific cellular markers found age-related loss of specific neuronal types. To test whether there is
age-related loss of specific neuronal populations in the hippocampus, and subsequently, whether
over-expression of the B-cell lymphoma protein-2 (Bcl-2) in these neurons could delay possible
age-related neuronal loss, we examined calretinin (CR) positive neurons in the mouse dentate
gyrus during aging.
Result: In normal mice, there was an age-related loss of CR positive cells in the dentate gyrus. At
the same region, there was no significant decrease of total numbers of neurons, which suggested
that age-related loss of CR positive cells was due to the decrease of CR expression in these cells
instead of cell death. In the transgenic mouse line over-expressing Bcl-2 in neurons, there was an
age-related loss of CR positive cells. Interestingly, there was also an age-related neuronal loss in
this transgenic mouse line.
Conclusion: These data suggest an age-related loss of CR positive neurons but not total neuronal
loss in normal mice and this age-related neuronal change is not prevented by Bcl-2 over-expression.
Background
Decline of cognitive functions, such as learning and mem-
ory, is often associated with aging, which plays a crucial
determinant of the quality of life in elderly population [1-
4]. Normal age-related deficits in learning and memory
resemble those caused by damage to the hippocampus. In
the hippocampus, electrophysiological studies demon-
strated age-related deficits in the induction and mainte-
nance of long-term potentiation (LTP), and lower
thresholds for potentiation and long-term depression [5-
7]. Despite such functional evidence for age-related dys-
function in the hippocampus, the cellular and molecular
bases of this decline are still unclear. Autopsy and mag-
netic resonance imaging-based volumetric measurements
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in normal elderly humans have shown hippocampal
shrinkage [8,9]. This atrophy could be theoretically
accounted for by age-related neuronal loss in the hippoc-
ampus. Early studies in many species did report neuronal
loss of hippocampal principal cells during aging [for
review, see [11]]. Subsequently, based on unbiased stere-
ological techniques to estimate neuron number, the over-
all results suggested that there was no widespread
hippocampal cell loss in both human and rodent models
during aging [12-18]. Despite maintenance of total neu-
ron number, there may be a loss of subpopulation of neu-
rons. The design-based stereological analysis may be
unable to detect changes in specific neuronal populations
because most of these studies focused on the total neuro-
nal population. Indeed, studies using specific molecular
markers clearly showed age-related decrease of specific
neuronal populations, which could contribute to age-
related functional decline of brain functions [19-22].
However, one detailed study found that age-related loss of
hippocampal interneurons positive for glutamate decar-
boxylase-67 (GAD-67, a key synthesizing enzyme for
GABA) was due to loss of GAD-67 expression rather than
neuronal loss [23]. Thus, it remained unclear whether
there was any age-related neuronal loss.
If there was age-related neuronal loss or age-related
changes of specific neuronal types, the next important
question is whether these age-related neuronal changes
could be prevented. One particular protein, the proto-
oncogene B-cell lymphoma protein-2 (Bcl-2), has been
shown to prevent both apoptotic and necrotic neuronal
death [24]. Bcl-2 gene is originally identified in B-cell lym-
phoma where its deregulated expression protects cells
from apoptosis [25-27]. In the nervous system, Bcl-2 is
detected and had been shown to protect neurons from
undergoing apoptosis during early development or neuro-
nal insults by a wide variety of stimuli, including growth
factor deprivation and oxidation stress [28-31]. However,
Bcl-2 over-expression does not prevent mutant neurofila-
ment-mediated motor neuron degeneration [32]. In the
cerebellum, over-expression of the human Bcl-2 transgene
with a neuron-specific enolase (NSE) promoter initially
increase the number of Purkinje cells by preventing neu-
ronal death during development, but subsequently can-
not prevent age-related loss of these neurons [33]. In the
hippocampus, Bcl-2 expression is decreased during aging
[34]. It is still unknown whether Bcl-2 over-expression can
prevent age-related loss of specific neuronal populations
in the hippocampus.
In the dentate gyrus of mouse hippocampus, several high-
affinity cytosolic calcium binding proteins such as parval-
bumin, calbindin, and calretinin (CR) have been shown
to be excellent chemical markers for certain interneurons
(35–41). A majority of interneurons in the hilus are posi-
tive for CR [35-38]. Based on detailed histological exami-
nations, these CR positive neurons in the hilus are mossy
neurons [39-41]. CR is also an early and specific marker of
newly generated adult-born neurons located near the edge
of the hilus at the subgranule zone (SGZ). Its expression
can be detected as early as one day after the neuron is born
and last less than six weeks [37]. Our preliminary studies
found over-expression of Bcl-2 transgene in this neuronal
population from mice expressing the human Bcl-2 gene
under the control of the neuron-specific enolase promoter
(the NSE73a line). Based on these previous detailed stud-
ies, we sought to focus on this population of CR positive
interneurons to test whether there was age-related loss of
interneurons in the mouse dentate gyrus, and whether
Bcl-2 over-expression could prevent age-related loss of
this neuronal population.
Results
Expression of human Bcl-2 in mouse hippocampus
To examine the expression of human Bcl-2 gene in the
hippocampus of the transgenic mice, we prepared lysates
from hippocampuses of 18 month-old transgenic and
wild type mice. These samples were analyzed by Western
blotting using a monoclonal antibody that does not cross-
react with mouse Bcl-2. Human Bcl-2 was detected in the
hippocampal lysates from transgenic mice (Fig. 1A).
Although immunohistochemistry from previous studies
indicated that expression of the human Bcl-2 was
restricted to neurons in this transgenic mouse line due to
the use of neuron-specific enolase promoter [33,42], the
expression pattern of human Bcl-2 in the dentate gyrus
was unknown. We found that the transgenic human Bcl-2
was expressed mostly in the hilus and co-localized with
CR positive interneurons (Fig. 1B). The expression of
human Bcl-2 was also found in CR positive cells at the
SGZ. In the granular cell layer, the transgene expression is
below the level to be detected (Fig. 1B).
Age-related decrease of CR positive neurons in the dentate 
gyrus
Since almost all co-localization of CR and Bcl-2 over-
expression were found in the hilus and the SGZ, the
number of CR positive neurons in these areas was esti-
mated for both control (normal C57BL/6J mice) and Bcl-
2 transgenic mice under C57BL/6J genetic background
with an unbiased stereology approach. At five-month old,
in comparison with the normal C57BL/6J mice, the
number of CR positive neurons within the hilus and SGZ
exhibited over 56% increase in the transgenic mice, which
was consistent with previous reports that more neurons
were found in this transgenic mouse line with Bcl-2 over-
expression [33,42,43]. However, at 18 month-old, there
were no differences in the number of CR positive neurons
between the control and transgenic mice. In comparison
with mice at five-month old, there was a significantMolecular Neurodegeneration 2006, 1:9 http://www.molecularneurodegeneration.com/content/1/1/9
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decrease of CR positive neurons for both control and
transgenic mice at 18 months old (P = 0.003, F = 14.752,
DF = 1, two-way ANOVA). For the control mice, there was
about 29% reduction of CR positive neurons in the den-
tate gyrus from 5 to 18 month-old; and for the transgenic
mice, there was about 59% reduction (Fig. 2A). Based on
the two-way ANOVA testing, there was no difference
between two genotypes (P = 0.144, F = 2.474, DF = 1), and
also no significant interaction between genotype and age
(P = 0.07, F = 4.039, DF = 1).
Because one detailed study clearly demonstrated that age-
related reduction in the number of GAD-67 positive
interneurons were due to age-related loss of GAD-67
expression rather that age-related neurons loss in the hip-
pocampus [23], we estimated the total neuronal numbers
in the same brain sections using the unbiased stereology
after the immunostaining of a neuronal marker, NeuN.
There was no age-related change in total neuronal num-
bers for normal C57BL/6J mice during aging (P = 0.43,
one-way ANOVA). Surprisingly, there was a significant
reduction (14%) of total neurons for the transgenic mice
during aging (P = 0.04, one-way ANOVA). Based on the
two-way ANOVA testing, there is no difference between
control and transgenic mice (P = 0.076, F = 4.14, DF = 1),
and there was no significant interaction between genotype
and age (P = 0.266, F = 1.431, DF = 1). These results sug-
gested that, in the control mice, age-related loss of CR pos-
itive neurons was due to a decrease of CR expression;
while in the transgenic mice; age-related loss of CR posi-
tive neurons was due to both an age-related decrease of
CR expression and age-related neuronal loss.
Analysis of age-related neuronal loss in the mouse dentate  gyrus Figure 2
Analysis of age-related neuronal loss in the mouse 
dentate gyrus. Mean number of CR positive neurons or 
total neurons were estimated in both wild-type (5 month-
old, n = 4; 18 month-old, n = 5) and NSE73a transgenic mice 
(5 month-old, n = 3; 18 month-old, n = 3). A) Mean number 
of CR positive neurons (+/- SD) estimated in the SGZ and 
hilus of the mouse dentate gyrus. Based on two-way 
ANOVA, There was a statistical difference between two age 
groups (P = 0.003), but there was no difference between two 
genotypes (P = 0.144), and there was not a statistically signif-
icant interaction between genotype and age (P = 0.07). B) 
Mean number of NeuN positive neurons (+/- SD) estimated 
in the same region as in (A). Based on two-way ANOVA, 
There was not a statistical difference between two age 
groups (P = 0.142), not a difference between two genotypes 
(P = 0.076), and not a significant interaction between geno-
type and age (P = 0.266).
Over-expression of Human Bcl-2 in the mouse hippocampus Figure 1
Over-expression of Human Bcl-2 in the mouse hip-
pocampus. A) Western-blots of the hippocampal lysates 
from 18 month-old C57BL/6J (WT, two mice) and NSE73a 
transgenic mice (Hu-Bcl-2, two mice). B) Co-localization of 
the transgenic Bcl-2 and CR in the hippocampus. Four layers 
of the mouse dentate gyrus are labeled on the overlay: M, 
molecular layer; G, granule cell layer; SGZ, sub-granule cell 
zone; and H, Hilus. The whole calibration length is 25 μm.Molecular Neurodegeneration 2006, 1:9 http://www.molecularneurodegeneration.com/content/1/1/9
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Proliferation rate of adult neurogenesis in the dentate 
gyrus during aging
However, there were several possible factors that could
influence the above findings. Since there is a consistent
adult neurogenesis in the SGZ, and one of these possibil-
ities was that Bcl-2 over-expression might change the pro-
liferation rate of adult neurogenesis during aging. For
example, an accelerated decrease of the proliferation rate
would mask a delay of age-related decrease of CR expres-
sion due to Bcl-2 over-expression. We examined the pro-
liferation rate of adult neurogenesis in both wild type and
transgenic mice with Ki-67 as a proliferate marker.
Although there was a dramatic decrease of the number of
Ki-67 positive cells from 2 month-old to 24 month-old
mice (P = 0.004, F = 16.604, DF = 1, two-way ANOVA), no
statistical difference was found between wild type and
transgenic mice (Fig. 3, P = 0.541, F = 0.407, DF = 1, two-
way ANOVA). There was also no significant interaction
between genotype and age (P = 0.410, F = 0.754, DF = 1,
two-way ANOVA). Thus, over-expression of human Bcl-2
did not affect the rate of adult neurogenesis during aging.
Molecular characterization of CR positive neurons in the 
dentate gyrus over-expressing Bcl-2
Another possibility that could complicate our conclusions
was that Bcl-2 over-expression disrupted CR expression
patterns in the dentate gyrus. In the normal mouse den-
tate gyrus, there are two populations of CR-positive neu-
rons in this region, CR positive neurons in the hilus are
mature hilar mossy neurons [40,41], while CR positive
cells at the SGL are early postmitotic neurons character-
ized by the transient CR expression, which starts one day
after cell division and ends around six weeks after [37].
Doublecortin (DCX) is a marker for progenitor and early
newborn neurons [44]. Thus, it should not be detected in
CR positive neurons in the hilus but should be present in
CR positive neurons in the SGZ. A similar pattern was pre-
served in the transgenic mice (Fig. 4A). Furthermore, at
the SGZ, there are two types of DCX and CR double-posi-
tive progenitor cells: early progenitor neurons without
any apical processes (less than 7 days old, the short arrow
in the Overlay) and late progenitor neurons with proc-
esses projected into the granule cell layer (7 days and
older, the long arrow in the Overlay) [44]. These two types
of progenitor cells were also found in the transgenic mice
(Fig. 4A). Using β-tubulin, a mature neuronal maker, we
found CR and β-tubulin double-positive neurons in the
hilus, consistent with CR positive cells in the hilus as
mature mossy neurons (Fig. 4B). Only very few CR posi-
tive cells were co-localized with β-tubulin at the SGZ.
These expression patterns were the same as reported in the
normal mice [39-41]. We did not find any difference in
these co-localization patterns between transgenic and
normal mice. Thus, Bcl-2 over-expression did not lead to
obvious abnormal CR expression patterns in the dentate
gyrus.
Distribution of CR positive neurons in dentate gyrus during 
aging
Since the dentate gyrus is a 3-D structure, it was possible
that Bcl-2 over-expression could disrupt the distribution
of CR neurons in this 3-D structure. Although it should
not affect the final conclusions because we used the unbi-
ased stereological counting method, it could introduce
large errors and reduce the sensitivity of our approach. We
thus examined age-related changes of CR neurons in the
dentate gyrus from septal (dorsal) to temporal (ventral)
Proliferation rate of adult neurogenesis using Ki-67 as a  marker Figure 3
Proliferation rate of adult neurogenesis using Ki-67 
as a marker. A) One example of GFP (green) and Ki-67 
(red) in a 2 month-old mouse dentate gyrus. The whole cali-
bration bar is 25 μm. B)Semi-quantification of Ki-67 positive 
cells in both wild-type (2 month-old, n = 3; 24-month-old, n 
= 3) and NSE73a transgenic mice (2 month-old, n = 3; 24-
month-old, n = 3) (+/- SE). Based on two-way ANOVA, 
There was a statistical difference between two age groups (P 
= 0.004), but there was no difference between two geno-
types (P = 0.541), and also no a statistically significant interac-
tion between genotype and age (P = 0.410).Molecular Neurodegeneration 2006, 1:9 http://www.molecularneurodegeneration.com/content/1/1/9
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regions in the transgenic mice. The distribution of CR pos-
itive neurons was very similar if not the same as the nor-
mal mice. At the septal region, one obvious difference
between young (2 month-old) and old (24 months-old)
mice was a dramatic decrease of CR positive neurons at
the SGZ in the dentate gyrus (Fig. 5). At the temporal
region, similar to previous findings [35], more CR positive
neurons were found in the hilus, compared to the septal
region (Fig. 5).
Changes of CR positive neurons at the SGZ during aging
Based on the above findings, we focused on the CR posi-
tive neurons at the SGZ of the septal area among three age
groups (2, 5, and 24 month-old). In both wild type and
transgenic mice over-expressing human Bcl-2, there was a
dramatic decrease of CR positive neurons at the SGZ, and
this could be observed as early as in the 5 month-old mice
(Fig. 6A). Semi-quantitatively, there was a dramatic
decrease of CR positive neurons at the SGZ during aging
(P = 0.001, F = 102.341, DF = 2, two-way ANOVA), and
there was a statistical difference between wild type and
transgenic mice (P = 0.002, F = 15.379, DF = 1, two-way
ANOVA). Compared to the wild type mice, there were
fewer CR positive neurons at the SGZ from 2 and 5
month-old transgenic mice (Fig. 6B). Thus, an increase of
CR positive neurons in the dentate gyrus of the Bcl-2
transgenic mice at five months of age (Fig. 2A) could be
only due to an increase of mossy neurons in the hilus, and
over-expressing of human Bcl-2 gene could not delay age-
related decrease of CR expression in mossy neurons at
later stages (over 18 month-old).
Discussion
The results presented here reveal a consistent age-related
loss of CR positive neurons in the mouse dentate gyrus.
However, in normal mice, this age-related loss is due to a
decrease of CR expression without significant neuronal
loss. Over-expressing Bcl-2 does not prevent this age-
related loss of CR positive neurons. Unexpectedly, Bcl-2
Spatial distribution of CR positive cells in the dentate gyrus  of NSE73a transgenic mice Figure 5
Spatial distribution of CR positive cells in the dentate 
gyrus of NSE73a transgenic mice. In the dentate gyrus 
of 2 month-old mice, the number of CR positive cells distrib-
uted at the SGZ was much higher in the septal region (A) 
that in the temporal region (B) of the dentate gyrus, and the 
number of the hilular CR positive cells was much higher in 
the temporal region than in the septal region. The same dis-
tribution pattern held in the dentate gyrus of 24 month-old 
mice although the number of CR positive cells at both hilus 
and SGZ was less that the number in 2 month-old mice. The 
whole calibration bar is 25 μm.
Characterization of CR positive cells in the dentate gyrus Figure 4
Characterization of CR positive cells in the dentate 
gyrus. A) Co-localization of CR with DCX at the SGZ. No 
co-localization was observed in the hilus. At the overlay 
panel, the long arrow points an example of late progenitor 
cells with processes and the short arrow an early progenitor 
cell without any apical processes. B) Co-localization of CR 
with β-tubulin in the dentate gyrus. β-tubulin is a neuronal 
specific molecular marker for mature neurons. Almost all CR 
positive cells were co-localized with β-tubulin in the hilus. 
The whole calibration bar is 25 μm.Molecular Neurodegeneration 2006, 1:9 http://www.molecularneurodegeneration.com/content/1/1/9
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over-expression leads to age-related neuronal loss in the
dentate gyrus.
CR positive neurons in the mouse dentate gyrus are well
characterized [37,39-41]. At the SGZ, CR is transiently
expressed in newly generated postmitotic neurons. Thus,
CR is a useful marker to measure adult neurogenesis [45].
Consistent with the previous studies showing an age-
related decrease of neurogenesis in the dentate gyrus [46],
we found a clear age-related loss of CR-positive cells at the
SGZ. Interestingly, over-expression of Bcl-2 decreases this
population of CR positive cells around two to five month-
old. This finding seems to contradict the previous finding
made using DCX as a molecular maker in the same trans-
genic mice [47], which found a significant increase of
DCX positive cells in the region including the granule cell
layer and SGZ around two-month old. There are two obvi-
ous differences between our study and their study. First of
all, different molecular markers were used (DCX vs. CR),
and DCX is expressed in both proliferating progenitor
cells and newly generated postmitotic neurons. Second,
different areas were investigated: both SGZ and granular
cell layer in their study and the SGZ only in our study.
However, we found a high level of co-localization for
these two markers in the SGZ and only a few cells positive
for both markers at the granular cell layer. Therefore, there
may be other factors contributing to the difference, for
example, we found that it was hard to precisely count
DCX positive cells because not only cell bodies but also
extensive processes were labeled. With CR as a molecular
marker, we were able not only to easily count the positive
cells but also to observe a similar trend between control
and transgenic mice at three different age groups (2, 5 and
24 month-old). Based on these data, and other control
experiments we did, we have concluded that Bcl-2 over-
expression could not delay age-related decrease of adult
neurogenesis.
In the hilus, CR positive neurons located at the ventral
part of the hilus are mossy cells, which receive innerva-
tions from mossy fibers of granule cells in the dentate
gyrus [48]. Mossy neurons in turn project to the ipsi- and
contra-lateral inner molecular layer and make excitatory
synapses on proximal dendrites of granule cells [49].
Adult neurogenesis does not contribute to this population
of neurons [37]. With the unbiased stereological
approach to estimate total CR positive cells in the region
including both the SGZ and hilus, we found more CR pos-
itive neurons at 5 month-old transgenic mice compared to
the control mice. Because the number of CR positive cells
was less at the SGZ in the transgenic mice, it is reasonable
to assume that there were more CR positive cells (or
mossy cells) in the hilus of the transgenic mice. Because
the total number of neurons in the hilus was similar
between the transgenic and control mice, Bcl-2 over-
expression may either selectively increase CR positive neu-
rons or up-regulate CR expressions in the hilus, which was
hard to distinguish in the present study. Another caveat
was that the immunoreactive intensity for NeuN was not
as strong as CR; therefore, there was a tendency to under-
estimate the total neuronal number by using NeuN as a
marker. However, using the same transgenic line, one pre-
vious study found an early increase of the Purkinje cells
and a return to near the normal level during aging [33].
Similar to their findings in the cerebellum, we found no
difference in the number of CR positive cells between the
control and transgenic mice at 18-month old, which sug-
Age-related decease of CR positive cells at the SGZ Figure 6
Age-related decease of CR positive cells at the SGZ. 
A)Dramatic decrease of CR positive cells at the SGZ during 
aging. The whole calibration bar is 25 μm. B) Semi-quantifica-
tion of CR positive cells at the SGZ in both wild-type (total 9 
mice, 3 for each age group) and NSE73a transgenic mice 
(total 9 mice, 3 for each age group) (+/- SE). Based on two-
way ANOVA, There was a statistical difference between two 
age groups (P = 0.001), between two genotypes (P = 0.002), 
and a significant interaction between genotype and age (P = 
0.049).Molecular Neurodegeneration 2006, 1:9 http://www.molecularneurodegeneration.com/content/1/1/9
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gests that Bcl-2 over-expression can not prevent age-
related loss of CR positive cells. Furthermore, Bcl-2 over-
expression leads to age-related neuronal loss while there is
no significant neuronal loss in the control animals during
aging. Since this transgenic line shows a deficit of allocen-
tric navigation in the water maze and a decrease of LTP
amplitude [50], one possible reason for this observation
is that Bcl-2 over-expression at early development stages
could result in abnormal neuronal connections, which
leads to abnormal neuronal activities, and subsequently
accelerated neuronal loss during aging.
In conclusion, we present strong evidence for age-related
loss of CR positive cells in the mouse dentate gyrus and
this loss is not prevented by Bcl-2 over-expression. The
age-related decrease of CR is likely to contribute to age-
related functional decline of nervous system. The absence
or reduction of CR in mossy neurons has been associated
with a complete blockade of dentate LTP induction in
mice [51,52]. The cause of this blockade may due to
decreased calcium buffering capacity in hillar mossy cells,
which leads to abnormal changes in synaptic transmis-
sion. A similar change in the mouse dentate gyrus may
happen during aging, which could be one of the cellular
mechanisms underlying age-related decrease of the den-
tate LTP. Furthermore, age-related decrease of CR expres-
sion could also deprive these neurons of the capacity to
buffer intracellular calcium and thus leave them vulnera-
ble to calcium excitoxicity during aging.
Materials and methods
Animals
C57BL/6J mice and mice expressing the human Bcl-2 gene
under the control of the neuron-specific enolase promoter
(the NSE73a line) were bred in the CID animal care facil-
ity at Washington University in St. Louis. All experimental
protocols were approved by the Institutional Animal Care
and Use Committee (Washington University/CID). In
order to reduce the possibility of effects of other genes co-
segregating with the bcl-2 transgene, the Bcl-2 over-
expressing transgenic mice were backcrossed to C57BL/6J
for at least 8 generations prior to the onset of our studies.
The genotype of each mouse was determined by tail-clip
DNA analysis using PCR. A total of 24 C57BL/6J and 21
transgenic mice were used for the data analysis. The detail
usage of animals for each experiment group was listed
(Table 1).
Tissue preparation and immunohistochemistry
Mice were transcardially perfused with 2% paraformalde-
hyde and 2% glutaraldehyde in 0.1 M sodium phosphate,
PH 7.6. The brains were removed and kept in the fixative
overnight and then transferred into 30% sucrose. Tissue
samples were immersed in OCT compound (Sakura Fine-
tek USA, Torrance, CA) and frozen on dry ice. Cryostat
sections were cut. The sections were stored at – 20 C in cry-
oprotectant with 25% ethylene glycol, 25% glycerin, and
0.05 M phosphate buffer. Free-floating immunohisto-
chemistry was used for all sections. Two different immu-
nostaining methods were applied: the peroxidase method
(ABC system, Vectastain, Vector Laboratories) for anti-CR
immunostaining (rabbit anti-CR, 1:1000, Chemicon) on
20 μm sections; and immunoflurescent labeling for CR,
human Bcl-2 (1:1000, PharMingen, San Diego, CA), neu-
ron-specific nuclear antigen (NeuN) (1:500, Chemicon),
doublecortinin (1:1000, Santa Cruz Lab.), Ki67 (1:500,
BD Biosciences Pharmingen), and β-tubulin (1:500, Cov-
ance) on 40 μm sections. Fluorescent sections were
mounted with DAP (to label the nuclei) in polyvinyl alco-
hol with diazbicyclo-octans as antifading agent.
Stereology
To precisely examine possible age-related neuronal loss in
the hilus during aging, we estimated the number of CR or
NeuN positive neurons in the hilus by using the optical
volume fractionator procedure. This method employs a
design-based, systematically random, multilevel sampling
protocol that combines the optical dissector and fraction-
ator methods to estimate subregion volume and cell
number. The area and distribution of the dissector count-
ing frames employed were dependent upon the region
and cell type under examination. For counting CR or
NeuN positive cells, the sampling grid area was 120 × 120
μm, the dissector size for each area was 50 × 50 μm using
the 100 × oil immersion objective lens, and the dissector
height was 4 μm. The volume was estimated by the prod-
uct of the summed volume of a systematic sub-sample
(every 4th section) throughout the entire structure. The
average section thickness was calculated from the section
thickness at each position over the sections where a dissec-
tor was systematically placed. Since counting efficiency
(the number of cells to be counted in each subsection) is
dependent on the counting error and biological variabil-
ity, a random mix of five young and old animals was used
to determine the counting efficiency (CE) by calculating
the observed coefficient of error and the observed coeffi-
cient of variation on relatively thick (40 μm) sections. The
average CE for this study was 0.012. The most difficult
obstacle with this approach was outlining the hilus based
on the polymorphism nuclear regions between the blades
of the hilus and the granular cell layer. We failed to con-
sistently outline the hilus (theoretically two nuclei layers
away from the granular cell layer) after numerous prelim-
inary experiments. However, we were able to consistently
outline the hilus and SGZ together based on the staining
pattern of nuclei and CR immunostaining. Thus, we first
estimated the total cell numbers of CR and NeuN positive
neurons in the region including both the hilus and SGZ
with the optical volume fractionator procedure. We then
semi-quantitatively estimated the number of CR positiveMolecular Neurodegeneration 2006, 1:9 http://www.molecularneurodegeneration.com/content/1/1/9
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neurons in the SGZ since the optical fractionator cannot
be used at the SGZ due to its thickness (only one- to two-
cell thick). For this semi-quantification, images of all
brain sections from the whole brain were taken under a
dissection scope after CR immunostaining. Ten sections
with similar dorsoventral level from each were selected
among different age groups. For a given section, all CR
positive neurons in the SGZ at the dorsal dentate gyrus
were counted by an observer blind to the experimental
conditions. Cell counts were then summed across the ten
sections and divided by ten. Similar approaches were used
for counting of Ki-67 positive cells in the SGZ.
Statistical analysis
The procedures based on West [53] were employed for
estimating the observed coefficient of variation and
observed coefficient of error in the estimations. Two-way
ANONA analysis of variance (SigmaPlot software) was
employed to evaluate differences among different age,
genotype, and the interaction between age and genotype.
Data are presented as mean +/- standard deviation (SD).
A p-value less than 0.05 were considered statistically sig-
nificant.
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